San Luis Obispo, CA -- OpeningBellReport.com initiates single day alert coverage on YaFarm Technologies (YFRM).
YaFarm Technologies announced this morning that it has signed a definitive agreement with the integrative Stem Cell Institute. YaFarm Technologies President Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and Accreditation Canada International. With a seasoned and successful management team in place, we believe we are creating an organization that has the capabilities to understand and support the many facets of the stem cell industry. We believe that there will be significant growth opportunities in stem cell research and treatment in the near future, and it is our intent to capitalize on them."
The company also announced a 4 for 1 forward stock split for shareholders on record as of January 18th, 2013.
For continued coverage on YaFarm Technologies, please sign up for the free report at: OpeningBellReport.com
OpeningBellReport.com issues momentum alerts on stocks that can provide gains to day traders. OpeningBellReport.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver significant gains in the short term. OpeningBellReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Leave a comment...